Cargando…

Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy

BACKGROUND: This study was conducted to assess the prognostic value of the number of negative lymph nodes (NLNs) in breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy (PMRT). METHODS: This retrospective study examined 605 breast cancer patients with four...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, San-Gang, Sun, Jia-Yuan, Zhou, Juan, Li, Feng-Yan, Zhou, Hao, Lin, Qin, Lin, Huan-Xin, Bao, Yong, He, Zhen-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278342/
https://www.ncbi.nlm.nih.gov/pubmed/25511525
http://dx.doi.org/10.1186/s13014-014-0284-5
_version_ 1782350512777068544
author Wu, San-Gang
Sun, Jia-Yuan
Zhou, Juan
Li, Feng-Yan
Zhou, Hao
Lin, Qin
Lin, Huan-Xin
Bao, Yong
He, Zhen-Yu
author_facet Wu, San-Gang
Sun, Jia-Yuan
Zhou, Juan
Li, Feng-Yan
Zhou, Hao
Lin, Qin
Lin, Huan-Xin
Bao, Yong
He, Zhen-Yu
author_sort Wu, San-Gang
collection PubMed
description BACKGROUND: This study was conducted to assess the prognostic value of the number of negative lymph nodes (NLNs) in breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy (PMRT). METHODS: This retrospective study examined 605 breast cancer patients with four or more positive lymph nodes who underwent mastectomy. A total of 371 patients underwent PMRT. The prognostic value of the NLN count in patients with and without PMRT was analyzed. The log-rank test was used to compare survival curves, and Cox regression analysis was performed to identify prognostic factors. RESULTS: The median follow-up was 54 months, and the overall 8-year locoregional recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overall survival (OS) were 79.8%, 50.0%, 46.8%, and 57.9%, respectively. The optimal cut-off points for NLN count was 12. Univariate analysis showed that the number of NLNs, lymph node ratio (LNR) and pN stage predicted the LRFS of non-PMRT patients (p < 0.05 for all). Multivariate analysis showed that the number of NLNs was an independent prognostic factor affecting the LRFS, patients with a higher number of NLNs had a better LRFS (hazard ratio = 0.132, 95% confidence interval = 0.032-0.547, p =0.005). LNR and pN stage had no effect on LRFS. PMRT improved the LRFS (p < 0.001), DMFS (p = 0.018), DFS (p = 0.001), and OS (p = 0.008) of patients with 12 or fewer NLNs, but it did not any effect on survival of patients with more than 12 NLNs. PMRT improved the regional lymph node recurrence-free survival (p < 0.001) but not the chest wall recurrence-free survival (p = 0.221) in patients with 12 or fewer NLNs. CONCLUSIONS: The number of NLNs can predict the survival of breast cancer patients with four or more positive lymph nodes after PMRT. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-014-0284-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4278342
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42783422014-12-30 Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy Wu, San-Gang Sun, Jia-Yuan Zhou, Juan Li, Feng-Yan Zhou, Hao Lin, Qin Lin, Huan-Xin Bao, Yong He, Zhen-Yu Radiat Oncol Research BACKGROUND: This study was conducted to assess the prognostic value of the number of negative lymph nodes (NLNs) in breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy (PMRT). METHODS: This retrospective study examined 605 breast cancer patients with four or more positive lymph nodes who underwent mastectomy. A total of 371 patients underwent PMRT. The prognostic value of the NLN count in patients with and without PMRT was analyzed. The log-rank test was used to compare survival curves, and Cox regression analysis was performed to identify prognostic factors. RESULTS: The median follow-up was 54 months, and the overall 8-year locoregional recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overall survival (OS) were 79.8%, 50.0%, 46.8%, and 57.9%, respectively. The optimal cut-off points for NLN count was 12. Univariate analysis showed that the number of NLNs, lymph node ratio (LNR) and pN stage predicted the LRFS of non-PMRT patients (p < 0.05 for all). Multivariate analysis showed that the number of NLNs was an independent prognostic factor affecting the LRFS, patients with a higher number of NLNs had a better LRFS (hazard ratio = 0.132, 95% confidence interval = 0.032-0.547, p =0.005). LNR and pN stage had no effect on LRFS. PMRT improved the LRFS (p < 0.001), DMFS (p = 0.018), DFS (p = 0.001), and OS (p = 0.008) of patients with 12 or fewer NLNs, but it did not any effect on survival of patients with more than 12 NLNs. PMRT improved the regional lymph node recurrence-free survival (p < 0.001) but not the chest wall recurrence-free survival (p = 0.221) in patients with 12 or fewer NLNs. CONCLUSIONS: The number of NLNs can predict the survival of breast cancer patients with four or more positive lymph nodes after PMRT. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-014-0284-5) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-16 /pmc/articles/PMC4278342/ /pubmed/25511525 http://dx.doi.org/10.1186/s13014-014-0284-5 Text en © Wu et al.; licensee BioMed Central. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wu, San-Gang
Sun, Jia-Yuan
Zhou, Juan
Li, Feng-Yan
Zhou, Hao
Lin, Qin
Lin, Huan-Xin
Bao, Yong
He, Zhen-Yu
Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
title Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
title_full Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
title_fullStr Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
title_full_unstemmed Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
title_short Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
title_sort number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278342/
https://www.ncbi.nlm.nih.gov/pubmed/25511525
http://dx.doi.org/10.1186/s13014-014-0284-5
work_keys_str_mv AT wusangang numberofnegativelymphnodescanpredictsurvivalofbreastcancerpatientswithfourormorepositivelymphnodesafterpostmastectomyradiotherapy
AT sunjiayuan numberofnegativelymphnodescanpredictsurvivalofbreastcancerpatientswithfourormorepositivelymphnodesafterpostmastectomyradiotherapy
AT zhoujuan numberofnegativelymphnodescanpredictsurvivalofbreastcancerpatientswithfourormorepositivelymphnodesafterpostmastectomyradiotherapy
AT lifengyan numberofnegativelymphnodescanpredictsurvivalofbreastcancerpatientswithfourormorepositivelymphnodesafterpostmastectomyradiotherapy
AT zhouhao numberofnegativelymphnodescanpredictsurvivalofbreastcancerpatientswithfourormorepositivelymphnodesafterpostmastectomyradiotherapy
AT linqin numberofnegativelymphnodescanpredictsurvivalofbreastcancerpatientswithfourormorepositivelymphnodesafterpostmastectomyradiotherapy
AT linhuanxin numberofnegativelymphnodescanpredictsurvivalofbreastcancerpatientswithfourormorepositivelymphnodesafterpostmastectomyradiotherapy
AT baoyong numberofnegativelymphnodescanpredictsurvivalofbreastcancerpatientswithfourormorepositivelymphnodesafterpostmastectomyradiotherapy
AT hezhenyu numberofnegativelymphnodescanpredictsurvivalofbreastcancerpatientswithfourormorepositivelymphnodesafterpostmastectomyradiotherapy